Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (211-220 of 496) with videos related to

Pageof 50
Sort By:
Cancer Epidemiology|January 8, 2019
Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Darren S Thomas, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 10, 2014
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screeningUsha Menon, Ahmed Talaat, Adam N Rosenthal, et al.
British Journal of Cancer|June 13, 2026
Can ovarian cancer screening work? A secondary analysis of the UK collaborative trial of ovarian cancer screeningJane M Lange, Ishfaq Ahmad, Isabel J Dengos, et al.
Biomarker Research|January 8, 2026
Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutationsUrszula Smyczynska, Aleksander Rycerz, Klaudia Kozlowska, et al.
Plos One|November 10, 2016
Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Mark Pennington, Aleksandra Gentry-Maharaj, Chloe Karpinskyj, et al.
Gynecologic Oncology|September 5, 2012
Psychological outcomes of familial ovarian cancer screening: no evidence of long-term harmKate E Brain, Kate J Lifford, Lindsay Fraser, et al.
British Journal of Cancer|January 16, 2020
Improved early detection of ovarian cancer using longitudinal multimarker modelsHarry J Whitwell, Jenny Worthington, Oleg Blyuss, et al.
American Journal of Obstetrics and Gynecology|July 28, 2019
Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal massesAleksandra Gentry-Maharaj, Matthew Burnell, James Dilley, et al.
Indian Journal of Endocrinology and Metabolism|April 5, 2016
Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjectsNeha Singhal, V P Praveen, Nisha Bhavani, et al.
Ecancermedicalscience|September 15, 2025
Conduct of cancer clinical trials: a qualitative study reporting views of patients, caregivers, public and clinical researchersSoumitra S Datta, Bidisha Samanta, Sanjoy Chatterjee, et al.
Pageof 50

Showing results (211-220 of 496) with videos related to

Sort By:
Pageof 50
Cancer Epidemiology|January 8, 2019
Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Darren S Thomas, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 10, 2014
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screeningUsha Menon, Ahmed Talaat, Adam N Rosenthal, et al.
British Journal of Cancer|June 13, 2026
Can ovarian cancer screening work? A secondary analysis of the UK collaborative trial of ovarian cancer screeningJane M Lange, Ishfaq Ahmad, Isabel J Dengos, et al.
Biomarker Research|January 8, 2026
Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutationsUrszula Smyczynska, Aleksander Rycerz, Klaudia Kozlowska, et al.
Plos One|November 10, 2016
Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Mark Pennington, Aleksandra Gentry-Maharaj, Chloe Karpinskyj, et al.
Gynecologic Oncology|September 5, 2012
Psychological outcomes of familial ovarian cancer screening: no evidence of long-term harmKate E Brain, Kate J Lifford, Lindsay Fraser, et al.
British Journal of Cancer|January 16, 2020
Improved early detection of ovarian cancer using longitudinal multimarker modelsHarry J Whitwell, Jenny Worthington, Oleg Blyuss, et al.
American Journal of Obstetrics and Gynecology|July 28, 2019
Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal massesAleksandra Gentry-Maharaj, Matthew Burnell, James Dilley, et al.
Indian Journal of Endocrinology and Metabolism|April 5, 2016
Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjectsNeha Singhal, V P Praveen, Nisha Bhavani, et al.
Ecancermedicalscience|September 15, 2025
Conduct of cancer clinical trials: a qualitative study reporting views of patients, caregivers, public and clinical researchersSoumitra S Datta, Bidisha Samanta, Sanjoy Chatterjee, et al.
Pageof 50